Literature DB >> 9117260

Neurocan and phosphacan: two major nervous tissue-specific chondroitin sulfate proteoglycans.

R K Margolis1, U Rauch, P Maurel, R U Margolis.   

Abstract

Neurocan is a multidomain hyaluronan-binding chondroitin sulfate proteoglycan that is synthesized by neurons, whereas the astroglial proteoglycan phosphacan is an mRNA splice variant representing the entire extracellular portion of a receptor-type protein tyrosine phosphatase. A glycoform of phosphocan (phosphocan-KS) that contains both chondroitin sulfate and keratan sulfate is present in the postnatal rat central nervous system (CNS). The concentration of neurocan in brain increases during late embryonic development but then declines steeply during the early postnatal period together with hyaluronan, and neurocan also undergoes extensive proteolytic processing during the course of brain development. In contrast, the concentrations of both phosphocan and phosphocan-KS rise steadily after embryonic day 20 to reach a plateau at about 2 weeks postnatally. In the embryonic CNS the distribution of neurocan mRNA is more widespread than that of phosphocan, which is primarily present in regions of active cell proliferation. Neurocan mRNA is also present in areas where the proteoglycan is not expressed, and there is evidence that the short open reading frame in its 5'-leader may function as a cis-acting regulatory signal for the modulation of neurocan expression in the developing CNS. Neurocan and phosphocan bind saturably, reversibly, and with high affinity to neural cell adhesion molecules (Ng-CAM/L1, NCAM, TAG-1/axonin-1) and to tenascin-C. The proteoglycans and their ligands have overlapping localizations in the CNS, and binding of phosphocan to Ng-CAM/L1, NCAM, and tenascin-C is mediated by complex-type N-linked oligosaccharides on the proteoglycan. Neurocan and phosphocan also bind to neurons and are potent inhibitors of neuronal and glial adhesion and neurite outgrowth. Through their interactions with neural cell adhesion and extracellular matrix molecules, these proteoglycans may play a major role in modulating cell adhesion, neurite growth, and signal transduction across the plasma membrane during the development of the CNS.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9117260

Source DB:  PubMed          Journal:  Perspect Dev Neurobiol        ISSN: 1026-7697


  30 in total

Review 1.  Physiology of angiogenesis.

Authors:  H Kurz
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

2.  Embryonic neurons adapt to the inhibitory proteoglycan aggrecan by increasing integrin expression.

Authors:  M L Condic; D M Snow; P C Letourneau
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

3.  Expression, crystallization and preliminary X-ray analysis of the extracellular Ig modules I-IV and F3 modules I-III of the neural cell-adhesion molecule L1.

Authors:  Nikolaj Kulahin; Christina Kasper; Ole Kristensen; Jette Sandholm Kastrup; Vladimir Berezin; Elisabeth Bock; Michael Gajhede
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-08-31

Review 4.  Extracellular matrix of the central nervous system: from neglect to challenge.

Authors:  Dieter R Zimmermann; María T Dours-Zimmermann
Journal:  Histochem Cell Biol       Date:  2008-08-12       Impact factor: 4.304

Review 5.  Podocalyxin as a major pluripotent marker and novel keratan sulfate proteoglycan in human embryonic and induced pluripotent stem cells.

Authors:  Hidenao Toyoda; Yuko Nagai; Aya Kojima; Akiko Kinoshita-Toyoda
Journal:  Glycoconj J       Date:  2017-01-11       Impact factor: 2.916

6.  Fungal brain infection modelled in a human-neurovascular-unit-on-a-chip with a functional blood-brain barrier.

Authors:  Jin Kim; Kyung-Tae Lee; Jong Seung Lee; Jisoo Shin; Baofang Cui; Kisuk Yang; Yi Sun Choi; Nakwon Choi; Soo Hyun Lee; Jae-Hyun Lee; Yong-Sun Bahn; Seung-Woo Cho
Journal:  Nat Biomed Eng       Date:  2021-06-14       Impact factor: 25.671

7.  Intravenous immune-modifying nanoparticles as a therapy for spinal cord injury in mice.

Authors:  Su Ji Jeong; John G Cooper; Igal Ifergan; Tammy L McGuire; Dan Xu; Zoe Hunter; Sripadh Sharma; Derrick McCarthy; Stephen D Miller; John A Kessler
Journal:  Neurobiol Dis       Date:  2017-08-18       Impact factor: 5.996

8.  The distribution of the proteoglycan FORSE-1 in the developing mouse central nervous system.

Authors:  Albert Kelly; Aisling O'Malley; Mohammad Redha; Gerard W O'Keeffe; Denis S Barry
Journal:  J Anat       Date:  2018-11-25       Impact factor: 2.610

9.  Impact of thyroid hormone deficiency on the developing CNS: cerebellar glial and neuronal protein expression in rat neonates exposed to antithyroid drug propylthiouracil.

Authors:  Gui-Hua Li; Jennifer Post; Noriyuki Koibuchi; Elizabeth M Sajdel-Sulkowska
Journal:  Cerebellum       Date:  2004       Impact factor: 3.847

10.  Reg1ulatory role and molecular interactions of a cell-surface heparan sulfate proteoglycan (N-syndecan) in hippocampal long-term potentiation.

Authors:  S E Lauri; S Kaukinen; T Kinnunen; A Ylinen; S Imai; K Kaila; T Taira; H Rauvala
Journal:  J Neurosci       Date:  1999-02-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.